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Abstract 
Objectives: To compare 12 weeks of exercise training at two intensities on oxidative stress, antioxidants 
and inflammatory biomarkers in patients with type 2 diabetes (T2D). 
Design: Randomized trial 
Methods: Thirty-six participants with T2D were randomized to complete either 12 weeks of treadmill 
based high-intensity interval training (HIIT) or moderate-intensity continuous training (MICT), 
followed by 40 weeks of home-based training at the same intensities. Plasma inflammation, oxidative 
stress and antioxidant biomarkers (total F2-isoprostanes, protein carbonyls, total antioxidant capacity, 
glutathione peroxidase activity, interleukin-10, interleukin-6, interleukin-8 and TNF-α) were measured 
at baseline, 12-weeks and 1-year. 
Results: There were no significant changes (p>0.05) in oxidative stress and inflammation biomarkers 
from baseline to 12-weeks in either intervention. A decrease in total antioxidant capacity in the MICT 
group from baseline to 1-year by 0.05 mmol/L (p=0.05) was observed. There was a significant 
difference (p<0.05) when groups were separated by sex with females in the MICT group having a 22.1% 
(p<0.05) decrease in protein carbonyls from baseline to 1-year. 
Conclusions: HIIT and MICT had no acute effect on oxidative stress and inflammatory biomarkers in 
patients with T2D. 
 
Keywords: High-intensity interval training, Moderate-intensity exercise, F2-Isoprostanes, Interleukin-
6, TNF-α, Protein carbonyls. 
 
 
 
Introduction 
Oxidative stress has been implicated in the pathogenesis of many diseases due to a significant 
increase in reactive species (RS).1 An excess of RS damages cellular proteins, lipids, and DNA and 
disrupts regular cellular function.1 Increased basal production of RS biomarkers is associated with 
T2D,2 and subsequently T2D is associated with oxidative stress and inflammation.3  
Chronic exercise training has been shown to decrease oxidative stress in many populations,4 
including individuals with T2D.5 Exercise improves the cellular antioxidant defence systems ability to 
counteract increases in RS, which enhances metabolic status and improves insulin sensitivity.5, 6 
However, the intensity of exercise needed to produce the most favourable changes in redox homeostasis, 
the balance between RS and antioxidants, is still under debate.7, 8, 9 High-intensity interval training 
(HIIT) is a time efficient way of increasing cardiorespiratory fitness with double the improvements in 
VO2peak in a shorter exercise time.
10 It has been suggested that HIIT may provide greater improvements 
in redox homeostasis regulation than traditional moderate-intensity continuous training (MICT).11 
Comparing the effects of different exercise intensities on redox regulation is yet to be studied in patients 
with T2D.  
Inflammation plays a major role in the pathogenesis of T2D and shares a cyclical relationship 
with oxidative stress.12 Exercise training reduces pro-inflammatory biomarkers,13 with several studies 
reporting that moderate intensity exercise decreases inflammation compared to low intensity exercise.14, 
15 However, the effects of higher intensity aerobic exercise on inflammatory biomarkers in patients with 
T2D has yet to be investigated.  
Therefore, the aim of this study was to determine the effects of exercise intensity on redox 
homeostasis and inflammatory biomarkers in individuals with T2D. We hypothesised that HIIT will 
elicit a greater reduction in oxidative stress, antioxidant and inflammatory biomarkers than MICT. 
 
 
Methods 
A randomised, two-group, parallel design was used. Thirty-six participants with T2D were 
allocated to either a HIIT or a MICT group (Table 1).  They completed 12 weeks of exercise training at 
the specified intensity with a combination of supervised and home based training. This was followed 
by a 40 week home-based training phase at the same intensity. Measurements were taken at baseline, 
12-weeks and 1-year. The protocol was approved by the Regional Committee for Medical and Health 
Research Ethics of Central Norway, the Medical Research Ethics Committee of the University of 
Queensland and was registered with the Clinical Trials Registry (NCT01206725) in September 2010. 
Written informed consent was obtained from all participants and they were insured through the 
intervention period.  
Inclusion criteria were; diagnosis of T2D less than ten years ago, non-insulin dependent, aged 
between 44 and 65 years, diastolic dysfunction (e’<8 cm/s) and achieving less than 210 minutes/week 
of exercise. Exclusion criteria included overt cardiovascular disease, coronary artery disease, moderate 
to severe valvular disease, atrial fibrillation, untreated hypertension, congenital heart disease, 
retinopathy, neuropathy, macroalbuminuria, ejection fraction < 40%, body mass index >35, ischemia at 
exercise echocardiograph or disease or disability making exercise training difficult. Participants were 
recruited through local newspaper advertising and from the outpatient population at St. Olav’s 
University Hospital, Trondheim, Norway.  
Upon arriving at the laboratory after a 12 hour fasting period, participants height and weight 
were measured, and a blood sample drawn from an antecubital vein. Informal questioning at the time 
of screening was performed to determine habitual physical activity time. Participants were asked to 
avoid strenuous exercise for 24 hours prior to testing. 
The exercise testing protocol started with a self –selected 10 minute warm up (3-6 km.h-1 at 0-
5% incline). After the warm up a facemask was placed on the participants for expired air gas analysis 
using a metabolic system (Jaeger LE2000CE, Hochberg, Germany). Before measuring VO2peak, 
participants were instructed to exercise to their maximum limit. The VO2peak test was performed using 
a ramp protocol where the speed was constant and the incline was increased 2% every two minutes until 
VO2peak was reached. Test durations were between 8 – 12 minutes. Heart rate was constantly monitored 
using a Polar RS 400 (Polar Electro, Kempele, Finland) to obtain maximum heart rate (HRmax). A 12-
lead ECG was used to monitor for any sign of silent ischemia during exercise. Post training exercise 
testing at 12 weeks and 12 months was performed at least 48 hours after the last training session at 
approximately the same time of day as at baseline. Exercise test supervisors provided verbal 
encouragement to the participant. 
After initial assessment for inclusion into the study, participants were randomised into exercise 
interventions by the Unit of Applied Clinical Research at the Norwegian University of Science and 
Technology using a random number generator into either HIIT or MICT. Allocation sequence was 
blinded to investigators by using an online process that provided the participant’s training group one at 
a time. 
The HIIT sessions started with warming-up for 10 minutes at 70% of HRmax before performing 
4x4 minute intervals at 90-95% of HRmax, interspersed with 3 minutes active recovery at 70% of 
HRmax and ending with a 5 minute cool-down period, giving a total of 40-min. HIIT training was 
performed 3 times per week. The exercise training sessions were supervised by an instructor and there 
was a doctor nearby in case of adverse reactions during training sessions. During the HIIT sessions, 
heart rate monitors (Polar RS 400; Polar Electro, Kempele, Finland) were used to ensure that the 
required exercise intensity was achieved and maintained. The training was performed at the test 
laboratory, at the Department of Circulation and Medical Imaging, St. Olav’s University Hospital, 
Trondheim, Norway. A defibrillator and emergency medicine (including insulin, glucagon and free 
glucose) were available in the laboratory. 
The MICT sessions were home based exercise sessions equivalent to the current exercise 
guidelines as set by the Norwegian Directorate of Health. In total, 210 minutes per week of unsupervised 
moderate intensity (~70% HRmax) exercise was accumulated in bouts that were a minimum of 10 
minutes in duration. Participants were instructed verbally to exercise to the level of breathing and 
sweating, but still be able to maintain a conversation of small sentences during exercise. Exercise 
adherence was self-reported and verbal encouragement to maintain the exercise regimen via telephone 
was performed twice during the intervention. Participants reported perceived effort and duration of 
exercise in minutes each day for the 12 week intervention. 
Once participants had completed the initial 12 week training phase they were instructed to 
complete 40 weeks of unsupervised home based training. Participants were asked to continue with the 
same regiment of exercise they performed during the initial intervention. During this 40 week period 
participants received two phone calls or emails to monitor their exercise adherence.  
Ethylenediaminetetraacetic acid vacutainers (Vacuette, Greiner Bio-One, Belgium) were used 
to collect all blood samples. Samples were immediately stored on ice before being centrifuged at 3000 
rpm for 10 minutes at 4°C. Separated plasma was aliquoted and stored at -80°C until biochemical assays 
were performed. Samples were shipped on dry ice to the University of Queensland, Brisbane, Australia 
for inflammatory and oxidative biomarker analysis.  
Plasma isoprostanes were analysed via gas chromatography mass spectrometry (Varian, 
Belrose, Australia) as we have previously described in Briskey et al.16 Briefly, isoprostanes were 
extracted from plasma after saponification with methanolic NaOH. 8-iso-PGF2α-d4 (Cayman 
Chemicals, Ann Arbor, MI) was used as an internal standard and added to samples before incubation at 
42 °C for 60 min. Samples were acidified to pH 3 with hydrochloric acid and hexane was added before 
10 minutes of centrifugation. The supernatant was removed and the remaining solution extracted with 
ethyl acetate before being dried under nitrogen. Acetonitrile was used to reconstitute samples prior to 
drying in silanized glass inserts. Derivatization with pentafluorobenzylbromide and 
diisoproplyethylamine followed. Incubation for 30 minutes at room temperature preceded drying 
samples under nitrogen. Pyridine, bis(trimethylsilyl)trifluoroacetamide 99% and trimethlychlorosilane 
1% were added and incubated at 45 °C for 20 minutes. Finally hexane was added and samples were 
mixed before analysis. Our laboratory coefficient of variation for this assay is 7%.16 
Plasma protein carbonyls were analysed using an adaption of the Levine et al.17 method 
previously described in Mullins et al.18 Samples were incubated with 2,4 dinitrophenylhydrazine in 2.5 
M HCl for 1 hour in the dark. Plasma black were incubated in 2.5M HCl only. Samples were precipitated 
with 20% trichloroacetic acid (TCA) on ice and centrifuged at 10000g for 10 minutes. Supernatants 
were discarded, and the pellets resuspended in 10% TCA and centrifuged as above. Supernatants were 
removed and the pellets resuspended in 1:1 ethanol:ethylacetate solution. After centrifugation as above, 
the pellets were washed twice more in ethanol:ethylacetate solution. Pellets were then resuspended in 
6 M guanidinehydrocholride solution and 220 µL of samples and blanks were transferred to microplate 
wells and absorbance read at 370 nm with correction at 650 nm using a microplate reader (Fluostar 
Optima, BMG Labtech, Offenburg, Germany). PC concentration was normalised to plasma protein 
content measured using a Pierce BCA protein assay kit (Thermo Scientific, Victoria, Australia). Our 
laboratory coefficient of variation for this assay is 11.9%.18 
Plasma glutathione peroxidase activity was measured using an adaptation of the method from 
Wheeler et al.19 Glutathione peroxidase activity was measured as the rate of oxidation of nicotinamide 
adenine dinucleotide phosphate, reduced (NADPH) at 340 nm in a coupled reaction, cycling oxidised 
glutathione to reduced glutathione using glutathione reductase. The reduced glutathione is utilised by 
glutathione peroxidase when the reaction is started with the addition of t-butyl hydroperoxide. Our 
laboratory coefficient of variation for this assay is 2.4%.18 These measures were performed on an auto 
analyser (Cobas Mira, Roche Diagnostica, Basel, Switzerland).  
Total antioxidant capacity (TAC) was measured using a modified version of an assay preciously 
described,20 and adapted for an auto analyser (Cobas Mira, Roche Diagnostica, Switzerland). Plasma 
was incubated with metmyoglobin and 2,2’-azino-biz(3-ethylbenzothiazoline-6-sulphonic acid). Post 
incubation hydrogen peroxide was added and the sample was again incubated. Absorbance was 
measured spetrophotometrically to determine TAC. Our laboratory coefficient of variation for this assay 
is 1.9%.18  
Plasma cytokines (interleukins 6, 8, 10 and tumour necrosis factor-alpha) were measured using 
the Milliplex MAP Human High Sensitivity T Cell Magnetic Bead Panel Kit. The assay protocol was 
followed as set out by Millipore, and magnetic beads were analysed by a multiplex analyser (Athena 
Multi-lyte, Zeus Scientific, Raritan, NJ, USA). Our laboratory coefficient of variation for this assay is 
12.3%.21 
All data analyses were completed using SPSS software (version 22 for Windows, SPSS Inc., 
Chicago, IL). Normality testing of data using the Shapiro-Wilk test was performed. Outliers were 
identified using the Grubbs test. Data that was not normally distributed were analysed using Wilcoxon 
signed rank tests and Mann-Whitney U tests. No point measures or change values for redox homeostasis 
and inflammatory markers were normally distributed. Significance was assumed when p<0.05. 
 
Results 
Exercise session attendance was 93.7% for the HIIT intervention (supervised sessions) and 94% 
for MICT (self-reported) during the initial 12 week phase. There were no significant differences 
(p>0.05) between redox homeostasis and inflammatory biomarkers at baseline, 12-weeks or 1-year 
(Table 2). There were also no significant differences (p>0.05) in the change values from baseline to 12-
weeks or from baseline to 1-year in any of the biomarkers (Figures A – H). The decrease in total 
antioxidant capacity from baseline to 1-year in the MICT group of 0.05 mmol/L was close to significant 
(p=0.05).  
When groups were separated by sex, females in the MICT group were observed to have a 
decrease in protein carbonyls from baseline to 1-year (p=0.04). Males in the HIIT group had a decrease 
in protein carbonyls from 12-weeks to 1-year (p=0.02). Males in the MICT group had a decrease of 
total antioxidant capacity from baseline to 12-weeks (p=0.01).  
Between groups, males in the MICT group had increased protein carbonyls compared to males 
in the HIIT group by 0.18 U/mg protein (p=0.03) at 1-year (Table 2). Females had increased protein 
carbonyls in HIIT group by 0.26 U/mg protein (p=0.01) at 1-year than females in the MICT group 
(Table 2).  
It has been proposed that individuals with elevated oxidative stress and/or inflammation may 
respond differently to exercise interventions therefore we examined groups separated into elevated 
oxidative stress (EOS) (F2-isoprostanes > 250 pg/mL) and elevated inflammation (EI) (Interleukin-6 > 
3.5 pg/mL). No differences in changes from baseline to 12-weeks or from baseline to 1-year were found 
between exercise interventions in either EI or EOS. EOS had changes of 29.50 pg/mL (-48.85 – 107.85) 
and 93.7 pg/mL (-5.62 – 133.80) in F2-isoprostanes from baseline to 12-weeks in the HIIT and MICT 
groups, respectively. EI had changes of 1.91 pg/mL (0.75 – 2.89) and 2.57 pg/mL (2.15 – 2.96) in 
interleukin-6 from baseline to 12-weeks in the HIIT and MICT groups, respectively.   
 
 
 
Discussion 
This is the first study to compare the effects of HIIT with MICT on markers of oxidative stress 
and inflammation in patients with T2DM. The main findings were that there were no effects of either 
training intensity on circulating redox homeostasis or inflammatory biomarkers over the initial 12 week 
intervention period. We did find a trend (p=0.05) for HIIT maintaining total antioxidant capacity 
compared to MICT over the 1-year period, suggesting that a 1-year HIIT intervention is associated with 
maintenance of TAC in individuals with T2D. There were several differences when groups were 
separated by sex, namely that males in the MICT group had a decrease in TAC from baseline to 12-
weeks and females in the HIIT group had increased protein carbonyls at 1-year compared with the 
MICT group.  
Both males and females had alterations in protein carbonyl content. Of interest, these changes 
were seen in opposing intervention groups suggesting that the exercise interventions may be sex specific 
when analysing for protein carbonylation. Previous research into protein oxidation has shown no sex 
differences after acute bouts of exercise.22, 23  
It seems that neither HIIT nor MICT were able to improve oxidative stress or inflammatory 
status in individuals with T2D, which is in contrast to previous studies investigating antioxidant and 
anti-inflammatory properties of exercise interventions and exercise intensity.4, 24, 25 In T2D populations, 
exercise training has been found to act as an antioxidant and anti-inflammatory stimulator/promotor.26 
A review article discusses the various benefits of exercise to inflammatory status in individuals with 
T2D, namely that regular exercise is associated with lower pro-inflammatory factors (C-reactive 
protein, IL-6, TNF-α) and higher anti-inflammatory factors (adiponectin, IL-10).24 In our study we did 
not see any changes in IL-6, TNF-α or IL-10. 
Even though the expected decrease in oxidative stress and inflammation biomarkers was not 
observed after the exercise interventions, there was also no observable increase in these biomarkers 
either. It seems that while the exercise interventions were unable to change oxidative stress and 
inflammation biomarkers in this population, they were able to maintain the biomarker levels whilst also 
providing a host of physiological improvements which have previously been published.27  
Our study did not contain a non-exercise control group. If this group was included we may have 
seen increases in oxidative stress and inflammatory markers over the study period that would have been 
slowed by the HIIT and MICT. These findings may be somewhat limited, reflected by the small 
differences between groups, by the modest sample size and the narrow panel of oxidative stress and 
inflammation biomarkers, which should be improved in further studies. Whilst all appropriate measures 
were taken to reduce variability during the intervention there may have been outside factors during the 
1-year follow up that could have influenced results. Recently there have been studies illuminating the 
limitations of spot measures of oxidative stress. Spot measures (single time point measure) provide only 
a snap shot of information which may not accurately represent redox homeostasis or inflammatory 
status.18, 28 An assessment of the ability of the antioxidant and anti-inflammatory system to cope with a 
stress (e.g. exercise) may better evaluate the capacities of each system.18 
Conclusion 
In summary, both MICT and HIIT had no effect on oxidative stress and inflammation levels in 
this particular study group of individuals with T2D over a 12 week intervention period with a one year 
follow up. In addition the HIIT intervention was able to maintain TAC in the 12 month follow-up period 
whereas MICT was not. The inability for both MICT and HIIT to have a positive effect upon 
inflammation and redox homeostasis biomarkers during the 12 week supervised intervention period is 
in contrast to the current literature which suggests that exercise in individuals with T2D is beneficial to 
redox homeostasis and inflammatory health.  
 
Practical implications 
 Moderate intensity continuous training and high-intensity interval training have no effect on 
oxidative stress and inflammation in patients with type 2 diabetes  
 High-intensity interval training is effective at maintaining total antioxidant capacity over a 12 
month period, above that of moderate intensity continuous training 
 Females who completed moderate intensity continuous training for 12 months had a greater 
decrease in protein oxidation, above that of high intensity interval training. 
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Figure legend. 
Figure 1. Changes in oxidative stress and inflammatory biomarkers from baseline to 12-weeks, and 
from baseline to 1-year in HIIT and MICT groups. Data are presented as median and interquartile 
range. HIIT group denoted as X, MICT group denoted as ■. 
 
  
Table 1. Participant characteristics
 MICT (n=16) HIIT (n=20) P Value 
Female, n (%)  6 (37.5) 8 (40.0) 0.88 
Age (years) 54.9 ± 5.3 58.6 ± 5.0 0.04 
T2D duration (years) 3.2 ± 2.6  4.3 ± 2.2 0.20 
BMI (kg/m2) 29.6 ± 3.6 30.2 ± 2.7 0.62 
VO2peak (ml/kg/min) 31.5 ± 6.0 33.2 ± 7.4 0.46 
Smoking status, n (%) 0 (0) 1 (5) 0.38 
Waist circumference (cm)  106.09 ± 8.79 108.60 ± 7.70 0.37 
HbA1c (%) 6.65 ± 0.66 7.04 ± 1.19 0.26 
Triglycerides (mmol/l) 1.88 ± 0.78 1.81 ± 0.79 0.77 
HDL (mmol/l) 1.20 ± 0.29 1.30 ± 0.43 0.40 
LDL (mmo/l) 3.21 ± 0.91 3.12 ± 0.89 0.77 
Cholesterol (mmol/l) 5.25 ± 0.93 5.24 ± 1.03 0.96 
HOMA-IR 2.89 ± 1.61 2.68 ± 0.67 0.61 
Statin use 3 (18.75) 4 (20) 0.16 
Antidiabetic medication 11 (68.75) 17 (85) 0.42 
Antihypertension medication 7 (43.75) 6 (30) 0.39 
Antiplatelet medication 7 (43.75) 4 (20) 0.99 
Data are categorized in n (%) or mean ± SD. T2D, type 2 diabetes 
mellitus; BMI, body mass index; HDL, High-denisty lipoprotein 
cholesterol; LDL, Low-density lipoprotein cholesterol; HbA1c, glycated 
hemoglobin; HOMA-IR, homeostatic model assessment – insulin 
resistance. 
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Table 2. Oxidative stress, antioxidant, and inflammatory markers at baseline, 12-weeks, and 1-year 
Data are presented as median and interquartile range. * denotes significantly different from 12-weeks within group (p<0.05), † denotes significantly different between sex (p<0.05). 
  HIIT MICT 
  Baseline 12-weeks 1-year Baseline 12-weeks 1-year 
F2-isoprostanes (pg/mL) All 170.0 (137.0-208.1) 199.3 (155.2-217.9) 201.4 (164.9-250.8) 223.6 (152.3-264.2) 202.5 (164.5-270.8) 227.3 (194.5-271.1) 
 Males 175.1 (120.8-206.0) 183.0 (147.2-217.9) 194.6 (146.0-204.1) 223.6 (153.4-282.4) 193.9 (144.6-207.6) 194.6 (163.5-255.2) 
 Females 169.5 (145.5-199.9) 201.1 (185.5-224.3) 251.8 (221.7-272.7) 218.4 (162.6-257.1) 275.8 (197.7-356.6) 240.6 (237.5-271.1) 
Glutathione peroxidase activity (U/L) All 96.9 (90.3-104.7) 96.3 (88.4-99.5) 94.8 (84.1-101.2) 96.5 (93.0-103.0) 94.6 (91.8-101.6) 100.0. (96.5-101.8) 
 Males 99.9 (92.6-106.1) 96.3 (87.0-97.9) 95.4 (86.6-101.2) 97.3 (92.9-103.4) 96.7 (93.1-102.2) 100.1 (97.8-102.0) 
 Females 93.8 (90.2-101.0) 96.3 (90.8-103.3) 94.1 (84.1-99.9) 96.5 (93.7-99.9) 92.9 (89.9-95.0) 99.0 (96.5-101.3) 
Total antioxidant capacity (mmol/L) All 1.71 (1.65-1.75) 1.72 (1.66-1.75) 1.71 (1.67-1.74) 1.76 (1.67-1.77) 1.69 (1.67-1.73) 1.71 (1.66-1.74) 
 Males 1.74 (1.69-1.76) 1.74 (1.66-1.76) 1.71 (1.67-1.76) 1.76 (1.70-1.77) 1.69 (1.66-1.71)* 1.69 (1.63-1.70) 
 Females 1.70 (1.62-1.72) 1.67 (1.65-1.72) 1.69 (1.67-1.71) 1.73 (1.63-1.84) 1.72 (1.67-1.76) 1.74 (1.72-1.75) 
Protein carbonyls (U/mg protein) All 0.54 (0.44-0.61) 0.54 (0.39-0.57) 0.46 (0.39-0.68) 0.48 (0.43-0.55) 0.44 (0.38-0.66) 0.54 (0.48-0.63) 
 Males 0.61 (0.50-0.67) 0.54 (0.49-0.71) 0.40 (0.35-0.48)*† 0.48 (0.44-0.50) 0.43 (0.39-0.64) 0.58 (0.53-0.65)† 
 Females 0.52 (0.44-0.54) 0.35 (0.29-0.55) 0.73 (0.69-0.80)† 0.54 (0.43-0.62) 0.46 (0.39-0.68) 0.47 (0.21-0.62)*† 
Interleukin-10 (pg/mL) All 12.2 (6.56-30.8) 13.0 (5.70-24.5) 18.3 (6.60-28.5) 12.4 (6.46-20.2) 7.77 (0.33-16.2) 14.0 (5.76-16.8) 
 Males 23.2 (7.24-32.6) 14.2 (7.27-22.9) 19.3 (6.55-27.9) 16.1 (10.0-27.0) 10.4 (0.46-16.5) 14.5 (7.16-17.7) 
 Females 10.5 (5.45-13.3) 11.5 (2.65-26.5) 17.8 (9.55-28.7) 7.67 (5.81-11.2) 7.46 (1.55-11.4) 10.8 (4.70-16.4) 
Interleukin-6 (pg/mL) All 2.42 (0.76-4.49) 1.79 (1.00-3.48) 2.23 (1.07-4.10) 1.94 (1.30-3.10) 1.79 (0.75-2.97) 1.98 (1.20-3.51) 
 Males 2.75 (0.76-4.97) 2.12 (1.11-4.08) 2.1 (0.86-3.21) 2.21 (0.90-3.76) 1.05 (0.24-2.27) 2.58 (1.26-3.86) 
 Females 2.42 (1.32-3.52) 1.4 (0.68-2.87) 3.92 (1.78-4.65) 1.89 (1.46-2.16) 2.40 (1.75-3.04) 1.46 (1.20-2.49) 
Interleukin-8 (pg/mL) All 2.25 (1.30-3.90) 1.91 (1.38-3.16) 2.29 (1.25-3.52) 1.95 (1.48-2.20) 1.63 (0.91-2.41) 2.04 (1.35-2.98) 
 Males 3.32 (1.31-4.34) 2.05 (1.66-3.16) 2.05 (1.50-3.64) 1.90 (1.47-2.64) 1.35 (0.14-2.53) 2.20 (1.35-3.07) 
 Females 2.04 (1.47-2.65) 1.67 (0.50-2.70) 2.53 (1.24-2.88) 1.95 (1.67-2.00) 1.97 (1.40-2.24) 2.04 (1.44-2.66) 
TNF-α (pg/mL) All 2.67 (1.57-4.27) 1.72 (0.79-4.39) 2.68 (1.34-4.64) 2.83 (1.54-4.19) 2.13 (0.24-3.39) 3.80 (1.50-4.50) 
 Males 2.79 (1.76-5.88) 2.44 (1.30-4.87) 2.63 (1.27-3.77) 3.10 (1.83-4.54) 1.82 (0.22-3.66) 3.80 (2.58-4.20) 
 Females 2.18 (1.45-3.72) 1.21 (0.52-4.22) 4.61 (1.42-4.84) 2.32 (1.49-3.21) 2.13 (1.13-2.41) 3.42 (1.50-4.50) 
